Discrepant findings in immune responses to JC virus in patients receiving natalizumab

Chen S. Tan; Yiping Chen; Raphael P. Viscidi; R. Philip Kinkel; Marion C. Stein; Igor J. Koralnik

doi:10.1016/S1474-4422(10)70124-1

Discrepant findings in immune responses to JC virus in patients receiving natalizumab

Chen S. Tan^*, Yiping Chen, Raphael P. Viscidi, R. Philip Kinkel, Marion C. Stein, Igor J. Koralnik

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	565-566
Number of pages	2
Journal	The Lancet Neurology
Volume	9
Issue number	6
DOIs	https://doi.org/10.1016/S1474-4422(10)70124-1
State	Published - Jun 2010

Funding

CST has received research grants from the National Institutes of Health. RPK has received consulting fees from Biogen Idec, Teva Pharmaceuticals, and Novartis, lecture fees from Biogen Idec, and grant support from Biogen Idec and Genzyme. IJK has received honoraria from Bristol-Myers Squibb, Ono Pharmaceuticals, Merck Serono, Antisense, and Alnylam, and has received research grants from the National Institutes of Health, the Neuro-AIDS research consortium, and Biogen Idec. YC, RPV, and MCS have no conflicts of interest.

ASJC Scopus subject areas

Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1474-4422(10)70124-1

Cite this

@article{810797413042498493ea6e868cf0ca31,

title = "Discrepant findings in immune responses to JC virus in patients receiving natalizumab",

author = "Tan, {Chen S.} and Yiping Chen and Viscidi, {Raphael P.} and Kinkel, {R. Philip} and Stein, {Marion C.} and Koralnik, {Igor J.}",

note = "Funding Information: CST has received research grants from the National Institutes of Health. RPK has received consulting fees from Biogen Idec, Teva Pharmaceuticals, and Novartis, lecture fees from Biogen Idec, and grant support from Biogen Idec and Genzyme. IJK has received honoraria from Bristol-Myers Squibb, Ono Pharmaceuticals, Merck Serono, Antisense, and Alnylam, and has received research grants from the National Institutes of Health, the Neuro-AIDS research consortium, and Biogen Idec. YC, RPV, and MCS have no conflicts of interest.",

year = "2010",

month = jun,

doi = "10.1016/S1474-4422(10)70124-1",

language = "English (US)",

volume = "9",

pages = "565--566",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd",

number = "6",

}

TY - JOUR

T1 - Discrepant findings in immune responses to JC virus in patients receiving natalizumab

AU - Tan, Chen S.

AU - Chen, Yiping

AU - Viscidi, Raphael P.

AU - Kinkel, R. Philip

AU - Stein, Marion C.

AU - Koralnik, Igor J.

N1 - Funding Information: CST has received research grants from the National Institutes of Health. RPK has received consulting fees from Biogen Idec, Teva Pharmaceuticals, and Novartis, lecture fees from Biogen Idec, and grant support from Biogen Idec and Genzyme. IJK has received honoraria from Bristol-Myers Squibb, Ono Pharmaceuticals, Merck Serono, Antisense, and Alnylam, and has received research grants from the National Institutes of Health, the Neuro-AIDS research consortium, and Biogen Idec. YC, RPV, and MCS have no conflicts of interest.

PY - 2010/6

Y1 - 2010/6

UR - http://www.scopus.com/inward/record.url?scp=77952317127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952317127&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(10)70124-1

DO - 10.1016/S1474-4422(10)70124-1

M3 - Letter

C2 - 20494320

AN - SCOPUS:77952317127

SN - 1474-4422

VL - 9

SP - 565

EP - 566

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 6

ER -

Discrepant findings in immune responses to JC virus in patients receiving natalizumab

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this